Pneumolysin induced mitochondrial dysfunction leads to release of mitochondrial DNA by Nerlich, Andreas et al.
 
 
Pneumolysin induced mitochondrial dysfunction
leads to release of mitochondrial DNA
Nerlich, Andreas; Mieth, Maren; Letsiou, Eleftheria; Fatykhova, Diana; Zscheppang, Katja;
Imai-Matsushima, Aki; Meyer, Thomas F; Paasch, Lisa; Mitchell, Timothy; Tönnies, Mario;
Bauer, Torsten T; Schneider, Paul; Neudecker, Jens; Rückert, Jens C; Eggeling, Stephan;
Schimek, Maria; Witzenrath, Martin; Suttorp, Norbert; Hippenstiel, Stefan; Hocke, Andreas C
DOI:
10.1038/s41598-017-18468-7
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Nerlich, A, Mieth, M, Letsiou, E, Fatykhova, D, Zscheppang, K, Imai-Matsushima, A, Meyer, TF, Paasch, L,
Mitchell, TJ, Tönnies, M, Bauer, TT, Schneider, P, Neudecker, J, Rückert, JC, Eggeling, S, Schimek, M,
Witzenrath, M, Suttorp, N, Hippenstiel, S & Hocke, AC 2018, 'Pneumolysin induced mitochondrial dysfunction
leads to release of mitochondrial DNA', Scientific Reports, vol. 8, no. 1, 182. https://doi.org/10.1038/s41598-017-
18468-7
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Feb. 2019
1SCIentIfIC REPORTS |  (2018) 8:182  | DOI:10.1038/s41598-017-18468-7
www.nature.com/scientificreports
Pneumolysin induced 
mitochondrial dysfunction leads to 
release of mitochondrial DNA
Andreas Nerlich  1, Maren Mieth1, Eleftheria Letsiou1, Diana Fatykhova1, Katja Zscheppang1, 
Aki Imai-Matsushima2, Thomas F. Meyer2, Lisa Paasch1, Timothy J. Mitchell3, Mario Tönnies4, 
Torsten T. Bauer4, Paul Schneider5, Jens Neudecker6, Jens C. Rückert6, Stephan Eggeling7, 
Maria Schimek7, Martin Witzenrath1, Norbert Suttorp1, Stefan Hippenstiel1 & Andreas C. 
Hocke1
Streptococcus pneumoniae (S.pn.) is the most common bacterial pathogen causing community 
acquired pneumonia. The pore-forming toxin pneumolysin (PLY) is the major virulence factor of S.pn. 
and supposed to affect alveolar epithelial cells thereby activating the immune system by liberation of 
danger-associated molecular patterns (DAMP). To test this hypothesis, we established a novel live-
cell imaging based assay to analyse mitochondrial function and associated release of mitochondrial 
DNA (mtDNA) as DAMP in real-time. We first revealed that bacterially released PLY caused significant 
changes of the cellular ATP homeostasis and led to morphologic alterations of mitochondria in 
human alveolar epithelial cells in vitro and, by use of spectral live-tissue imaging, in human alveoli. 
This was accompanied by strong mitochondrial calcium influx and loss of mitochondrial membrane 
potential resulting in opening of the mitochondrial permeability transition pore and mtDNA release 
without activation of intrinsic apoptosis. Moreover, our data indicate cellular mtDNA liberation via 
microvesicles, which may contribute to S.pn. related pro-inflammatory immune activation in the human 
alveolar compartment.
Pneumonia remains the most frequent infectious disease and a major cause of morbidity and mortality being 
responsible for one third of deaths worldwide1. The most common pathogen causing community-acquired 
pneumonia (CAP) is Streptococcus pneumoniae (S.pn.)2. We and others already demonstrated that pneumococ-
cal infection of human lung cells and tissue induces a strong pro-inflammatory response and can further lead 
to cellular death3–6. However, it remains to be clarified which microbial factor is the predominant, what cellu-
lar events are activated, and if immunological consequences can be expected by the alveolar epithelial damage. 
The major virulence factor supposed to foster those effects is pneumolysin (PLY)7. PLY belongs to the group 
of cholesterol-dependent cytolysins produced by more than 40 gram-positive bacteria8. Autolytic as well as 
antibiotic-associated bacterial release of PLY allow binding to cholesterol rich cellular membranes leading to 
toxin oligomerization and subsequent formation of large pores (250–350 Å)7. This results in consecutive cellular 
homeostatic changes, mainly provoked by strong cytosolic calcium ([Ca2+]c) influx, which may pave the way 
for cell death induction and an overwhelming immune response leading to acute organ failure7 or short- and 
long-term cardiovascular complications9. Such uncontrolled impact on the cellular homeostasis immediately 
requires well-directed remedies by responsible organelles such as mitochondria, which are known to buffer 
[Ca2+]c excess. Under physiological conditions, well-regulated mitochondrial calcium levels ([Ca2+]m) contribute 
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Figure 1. Pneumolysin induces mitochondrial fragmentation and disrupts mitochondrial motility in epithelial 
cells and human lung tissue. (A) A549 cells were labelled with MitoTrackerOrange and subsequently infected 
with S.pn. D39Δcps or S.pn. D39ΔcpsΔply for 5 hours, stimulated with 1.0 µg/ml PLY for 15 min or left 
untreated. Cells were fixed, stained with DAPI and mitochondrial morphology was analysed by structured 
illumination microscopy. Mitochondria were pseudocoloured using YellowHot LUT and a reconstructed 
widefield image of the nucleus is shown in blue. Scale bar represents 5 µm. (B,C) Quantification of 
mitochondrial morphology in control and PLY treated cells exemplified in (A). The mitochondrial network was 
examined and quantified in stochastically selected mitochondria-rich parts of the cells. Integrative network/
shape analysis (number of branches per mitochondrion (B) and branch length per mitochondrion (C)) was 
performed (mean ± SD from n = 3 independent experiments, *P < 0.05, one-tailed Mann-Whitney test). 
(D) Quantification of mitochondrial mean velocity in A549 cells immediately before and five minutes after 
stimulation with 1 µg/ml PLY (mean ± SD from n = 4 independent experiments, *P < 0.05, one-tailed Mann-
Whitney test). (E) Human lung tissue was labelled with MitoTrackerOrange (cyan) and caspase-3/7 sensor 
(magenta) and was left untreated (ctrl, left), stimulated with 1.0 µg/ml PLY for 1 h (PLY, middle) or infected 
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to the preservation of membrane potential (ΔΨm) and adequate ATP generation10. However, exceeding the mito-
chondrial capacity can result into loss of those as well as opening of the Ca2+-sensitive mitochondrial permeabil-
ity transition pore (mPTP), organelle swelling, and release of pro-apoptotic factors such as cytochrome C (cytC) 
or apoptosis inducing factor (AIF)11,12. Since the mPTP spans the inner and outer mitochondrial membrane 
and it has been shown, that its opening contributes to the release of mitochondrial DNA (mtDNA) fragments13. 
Released mtDNA may then serve as intra-, or in case of external release, extracellular DAMP for immune acti-
vation14. However, the resulting cellular events after [Ca2+]c overload are not consequently uniform on the mito-
chondrion and depend on the biological stimulus. Thus, it remains to be elucidated if PLY induced [Ca2+]c influx 
has the potential to alter [Ca2+]m subsequently influencing ΔΨm, ATP generation as well as mPTP associated 
release of mtDNA.
Clarification of these mechanisms is of pivotal interest for the understanding of S.pn. induced immune activa-
tion since increasing evidence suggests that either cytosolically or micro-environmentally released mtDNA may 
be recognized by pattern recognition receptors (PRRs) as a DAMP15. Thereby, circulating mtDNA may indicate 
and foster severe inflammation in several disease conditions14. For the lung, the alteration of existential mito-
chondrial functions on the one hand, together with the liberation of mtDNA on the other may dispose a danger-
ous pathophysiological liaison indicating severe cellular injury16 leading to deleterious organ failure17–19.
These roles render mitochondria to central organelles for the control of innate immune responses as well as 
cellular fate in the alveolar compartment and we therefore investigated whether and how PLY affects mitochon-
drial function in human lung tissue and cultured pulmonary epithelial cells. First, by use of bacterial deletion 
mutants, we demonstrated that PLY is the major virulence factor altering mitochondrial morphology, motility, 
ΔΨm, and ATP. Second, the presence of PLY showed massive [Ca2+]m influx, opening of the mPTP and, by sup-
port of a novel live-cell based assay, mtDNA release independent of mitochondrial caspase activation. Finally, the 
liberation of mtDNA from the affected cells was found to be concentrated in PLY induced microvesicles.
Results
PLY is responsible for alteration of mitochondrial morphology and motility in epithelial cells 
and human lungs. To test whether PLY influences mitochondrial functions, we used the human alveolar 
epithelial cell line A549 and verified key results in original living human lung tissue explants by a novel spectral 
live-tissue imaging method, which we established for this purpose. First, analysing mitochondrial morphology 
in S.pn. D39Δcps, D39ΔcpsΔply (moi 50, 5 h) infected A549 cells or cells exposed to recombinant lytic PLY 
(1 µg/ml, 15 min) with the super-resolution technique structured illumination microscopy (SIM) showed strong 
mitochondrial fragmentation and organelle swelling compared to control or infection with PLY deficient mutants 
(Fig. 1A). To quantify the toxin induced morphological alterations, network analysis of SIM acquired z-stacks 
in mitochondria rich regions was performed. This analysis showed that PLY induced a 4.6-fold reduction of 
branches (Fig. 1B) and a 4.4-fold reduced branch length per mitochondrion (Fig. 1C) supporting the conclusion 
that mitochondrial morphology changes from a typical elongated and filamentous reticular network state to cir-
cular organelles. These morphological alterations were accompanied by a significantly reduced mitochondrial 
motility (mean speed reduction 2.9-fold), which was revealed by automatic tracking of individual mitochondria 
after confocal live-cell microscopy (Fig. 1D).
Since PLY treatment may cause strong [Ca2+]c influx, which may activate cell death mechanisms20, we per-
formed live-cell imaging with MitoTracker labelled mitochondria and a caspase-3/7 activity indicator. Cells were 
infected either with S.pn. D39Δcps or S.pn. D39ΔcpsΔply and afterwards PLY pores were stained by conven-
tional immunofluorescence with subsequent 3D rendering showing a clear correlation with caspase activation 
and mitochondrial change of morphology (Supplementary Movies 1 and 2).
Next, we proofed whether these morphological alterations and caspase-3/7 activation were similar in human 
alveolar epithelial cells embedded in their original three-dimensional tissue architecture. With the same labelling 
procedure, lungs were exposed to PLY (1 µg/ml, 1 h) or S.pn. D39-GFP (106 cfu/ml, 12 h) and spectral live-tissue 
imaging with linear unmixing of auto-fluorescence from overlapping spectra was performed. Untreated tissue 
showed moving alveolar epithelial cells with elongated, interconnected mitochondria that displayed normal 
motility (Fig. 1E left, Supplementary Movie 3). In contrast, strong fragmentation of mitochondria as well as 
caspase-3/7 activation in human lung tissue stimulated with PLY was observed (Fig. 1E middle), which corre-
lated with reduced mitochondrial motility (Supplementary Movie 4). By multi-colour spectral imaging and 3D 
rendering, the same effect was demonstrated in lungs infected with S.pn. D39-GFP (arrowheads). Liberated PLY 
(open arrowheads) from bacteria was additionally visualized by antibody labelling and showed insertion into 
the cell membranes of the alveolar epithelium in the human lung, which led to mitochondrial fragmentation and 
caspase-3/7 activation (asterisk, Fig. 1E right, Supplementary Movie 5). These results further underline that S.pn. 
induces PLY-dependent changes like mitochondrial fragmentation and disturbs motility, which seems to be an 
important virulence mechanism in human epithelial cells of the alveolar compartment.
PLY induced mitochondrial dysfunction and mPTP opening without release of pro-apoptotic 
factors. The morphological alterations of the mitochondria raised the question for critically impaired 
mitochondrial functions. ΔΨm is the driving force for ATP production, which was significantly reduced in 
with S.pn. D39-GFP for 12 h (D39-GFP, right). The tissue was analysed by spectral confocal microscopy. 
Autofluorescence of collagen fibres is shown in grey. In addition GFP-pneumococci are shown in red 
(arrowheads) and PLY in green (open arrowheads). The asterisk indicates accumulation of caspase-3/7 sensor in 
the nucleus. Scale bars, 5 µm.
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cells infected with S.pn. D39Δcps but was not in influenced in cells infected with bacteria deficient for PLY 
(D39ΔcpsΔply) (Supplementary Fig. S1). We next transfected cells with cytosolic or mitochondrial ATP-FRET 
vectors and used spectral-FRET analysis to assess the effect of either S.pn. and its PLY deficient mutant or PLY 
alone on cytosolic and mitochondrial ATP production. A clear dependency of PLY was revealed for reduced ATP 
in both cellular compartments, which is completely in line with loss of ΔΨm and distorted morphology (Fig. 2A 
and B). The comparison to oligomycin exposure (prototypic strong F0 proton channel inhibitor of the ATP syn-
thase serving as positive control) demonstrated that PLY effects on mitochondria were in the same range and 
must be considered as biologically significant (Oligomycin, Fig. 2A and B).
PLY related pore formation is known to increase [Ca2+]c concentration21, which may play an important role in 
signal transduction as well as cell death as a result of [Ca2+]m overload. Since we already found caspase-3/7 activa-
tion accompanied by mitochondrial alteration, we now used live-cell imaging in A549 cells to investigate whether 
PLY induced changes in [Ca2+]m and how this correlates with caspase-3/7 activation. Stimulation with 1 µg/ml 
PLY revealed an immediate rise in [Ca2+]m followed by a slightly lagged induction of caspase-3/7 indicating a cor-
relation of apoptosis induction and mitochondrial dysfunction (Fig. 3A, Supplementary Movie 6). Quantitative 
analysis showed maximal increase of [Ca2+]m approx. 60 s after stimulation with 1 µg/ml PLY (Fig. 3B) that slowly 
declined whereas the caspase-3/7 signal reached a plateau level after approximately 200 s (Fig. 3C). Treatment 
with a sub-lytic PLY concentration (0.1 µg/ml) induced a minor rise in [Ca2+]m that returned to baseline levels 
after about 300 s and was accompanied by a comparably low increase in caspase-3/7 activation (Fig. 3B and C, 
Supplementary Movie 7). Unstimulated cells served as baseline control (Fig. 3B and C, Supplementary Movie 8). 
Since strong uptake of Ca2+ by mitochondria can lead to ΔΨm depolarization, we correlated loss of ΔΨm in the 
same setting and revealed an immediate decrease in cells stimulated with 1 µg/ml PLY (Fig. 3D, Supplementary 
Movie 9). In contrast, cells treated with 0.1 µg/ml PLY showed slowly decreasing levels of ΔΨm dissipation over 
the observation period (Fig. 3D, Supplementary Movie 10), whereas the membrane potential in unstimulated 
cells remained constant (Fig. 3D, Supplementary Movie 11). The observed [Ca2+]m overload has been suggested 
to induce opening of the mPTP. In order to determine the status of the mPTP we used the Calcein/CoCl2 tech-
nique. As shown in Fig. 3E, stimulation with 1 µg/ml PLY induced a sharp decrease of the mitochondrial Calcein 
signal indicative for a rapid opening of the mPTP (Supplementary Movie 12). However, in comparison to the 
Figure 2. Infection with PLY expressing pneumococci and stimulation with PLY reduces cytosolic and 
mitochondrial ATP levels. A549 cells were transfected with plasmids encoding FRET-ATP sensors targeted to 
the cytosol (A) and mitochondria (B), respectively. 48 hours post transfection, cells were left unstimulated or 
infected with S.pn. D39Δcps, S.pn. D39ΔcpsΔply for 4 and 6 h, respectively, or stimulated with 0.25 µg/ml PLY 
for 30 min. Cells stimulated with 10 µg/ml Oligomycin for 30 min served as positive control. The ATP content is 
expressed as normalized ratio of the YFP/CFP peak intensity at 530 nm (YFP) and 478 nm (CFP), respectively 
measured by live spectral-FRET microscopy. Bars represent mean ± SD from n = 3 independent experiments. 
*P < 0.05, **P < 0.01; Kruskal-Wallis test with Dunn’s post-hoc test.
www.nature.com/scientificreports/
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slight effects observed with sub-lytic concentrations of PLY, we found a delayed but significant opening of the 
mPTP, which was not sufficient to induce caspase-3/7 activation in the measured interval (Fig. 3E, Supplementary 
Movie 13). The slight decrease in unstimulated cells most likely reflects bleaching/quenching of Calcein without 
opening of the mPTP (Fig. 3E, Supplementary Movie 14). Taken together, PLY induced dose-dependent rapid 
[Ca2+]m influx, correlated with caspase-3/7 activation and loss of ΔΨm, which was then accompanied by opening 
of the mPTP. Interestingly, the very low increase of [Ca2+]m with sub-lytic PLY was insufficient to induce signifi-
cant caspase-3/7 activation but finally led to ΔΨm depolarization and opening of the mPTP indicating a differen-
tial regulation of PLY at the mitochondrium.
Therefore, we tested the literature-based hypothesis that opening of the mPTP and the observed strong swell-
ing might be responsible for outer mitochondrial membrane (OMM) rupture for release of pro-apoptotic fac-
tors11,12. We overexpressed a mitochondrial inner membrane space targeted fluorescent protein (IMS-mEOS) 
or stained for apoptosis inducing factor (AIF, data not shown) and cytochrome-c (Supplementary Fig. 2A and 
B). In addition, we partitioned untreated and PLY-treated A549 cells into cytosolic and mitochondrial fractions 
Figure 3. The effect of PLY on mitochondrial calcium, caspase-3/7 activation, membrane potential and opening 
of mPTP. (A) Representative time-lapse images of A549 cells loaded with the mitochondrial calcium sensor 
Rhod2-AM (red) and stimulated with 1.0 µg/ml PLY in the presence of the caspase-3/7 sensor (green). Scale bar 
represents 25 µm. (B) Quantification of mitochondrial calcium changes (Rhod2 F/F0 ratios) in cells stimulated 
with 1.0 µg/ml and 0.1 µg/ml PLY or left untreated (mean ± SD from n = 5 independent experiments). (C) 
Quantification of caspase-3/7 induction (F/F0 ratios) in cells stimulated with PLY as described above or left 
untreated (mean ± SD from n = 3 independent experiments). (D) Quantification of changes in mitochondrial 
membrane potential (TMRE F/F0 ratios) in cells stimulated with PLY as described above or left untreated 
(mean ± SD from n = 3 independent experiments). (E) Opening of the mPTP (F/F0 ratios) in cells stimulated 
with the indicated amount of PLY or left untreated (mean ± SD from n = 3 independent experiments).
www.nature.com/scientificreports/
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and analysed the release of cytochrome-c and AIF from mitochondria into the cytosol by western blotting 
(Supplementary Fig. 2C). Noteworthy, although stimulation with 1 µg/ml PLY caused significant mitochondrial 
alterations, no release of the addressed proteins from mitochondria was found, indicating mPTP opening is inde-
pendent from activation of cellular apoptotic pathways on the one hand as well as independent from mitochon-
drial dysfunction on the other.
PLY induced mitochondrial DNA release. Mitochondrial dysfunction with opening of the mPTP might 
lead to release of mtDNA acting as a DAMP13. We next used a novel approach described in the Supplementary 
Note to quantify the release of mtDNA. Therefore, A549 cells were stained with Syto82 and MitoTrackerOrange 
followed by treatment with 1 µg/ml PLY. Analysis by spectral confocal live-cell microscopy showed a rapid 
release of Syto82 from mitochondria (Fig. 4A, Supplementary Movies 15 and 16). The kinetics (Fig. 4B) closely 
resembles the kinetics of mPTP opening (Fig. 3E) and are comparable to those obtained with PicoGreen stained 
cells (Supplementary Fig. 4A and B). The release of mtDNA from mitochondria was further validated by static 
immunofluorescence staining of mtDNA in fixed A549 cells treated with 1 µg/ml PLY for different time points 
(Supplementary Fig. 5). Quantitative analysis showed a significant mitochondrial release of DNA over time, albeit 
the release kinetics in this assay seem to be slower.
Whether the findings of mtDNA release in A549 cells upon PLY stimulation can be generalized is of impor-
tance. Due to technical reasons, Syto82 labelling of mtDNA in living human lung tissue was not possible and we 
therefore used isolated human pAEC. By using the same approach, we obtained similar results in pAEC with a 
slightly delayed release kinetic compared to controls (Fig. 4C and D). Taken together, these data show that PLY 
induces release of mtDNA from mitochondria in human alveolar epithelial cells.
PLY induced extracellular release of mtDNA. We next hypothesized that mtDNA fragments may 
be released from the cytosol into the cellular environment, where they potentially may alert nearby alveolar 
macrophages (AM) as DAMP for induction of downstream inflammatory responses19,22. Moreover, since it has 
recently been postulated that PLY induced the formation of extracellular vesicles as PLY pores clearance mech-
anism23 we tested if PLY was released freely into the supernatant or packed into small membranous vesicles. 
First, by qRT-PCR analysis, we compared levels of mtDNA release into the supernatant of PLY-stimulated A549 
cells. As shown in Fig. 5A, we observed a dose dependent increase of mtDNA. Due to small amounts and high 
Figure 4. Real-time measurements of PLY induced release of mtDNA in A549 and primary human alveolar 
epithelial cells. (A) Representative confocal 2D plane of mitochondria in A549 cells stained with Syto82 (red) 
and MitoTrackerOrange (grey) left unstimulated or stimulated with 1.0 µg/ml PLY for 5 min. The scale bar 
represents 15 µm. (B) Quantification of mtDNA release (Syto 82 F/F0 ratios) in cells stimulated as described 
above (mean ± SD from n = 5 independent experiments, ***P < 0.05, 2-way ANOVA). (C) Representative 
confocal 2D plane of mitochondria in primary human alveolar epithelial cells stained with Syto82 (red) and 
MitoTrackerDeepRed (grey) left unstimulated or stimulated with 1.0 µg/ml PLY for 5 min. The scale bar 
represents 15 µm. (D) Quantification of mtDNA release (Syto 82 F/F0 ratios) in cells stimulated as described 
above (mean ± SD from n = 3 independent experiments, ***P < 0.05, 2-way ANOVA).
www.nature.com/scientificreports/
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variation, we had to normalize the data, but most importantly, PLY concentrations leading to a rapid release of 
mtDNA from the mitochondria also led to significantly 3.2-fold (1.0 µg/ml) and 4.7-fold (2.0 µg/ml) increase 
of mtDNA into the supernatant (Fig. 5A). This was further validated by the established ρlow A549 cells, which 
showed a decreased release of mtDNA after 1 µg/ml PLY stimulation (Fig. 5B), comparable to their reduced 
amount of mtDNA (Supplementary Fig. 3C–E). Next, we treated A549 cells with sub-lytic concentrations of PLY 
(0.05 and 0.1 µg/ml) to avoid lytic cell damage and to allow regulated cellular processes. From such treated cells, 
the microvesicle fraction (Supplementary Fig. 6) was isolated and analysed for mtDNA content. Interestingly, 
compared to supernatants alone, we found a relatively high amount of mtDNA, even with very low doses of PLY 
indicating a defined alert mechanism of alveolar epithelial cells by DAMP containing microvesicle liberation 
(Fig. 5C). In addition, we investigated if mtDNA would also be released in living human lung tissue explants. 
Treatment with 5 µg/ml PLY led likewise to an increased amount of mtDNA whereas treatment with 5 µg/ml PLY 
in the presence of 5 U/ml DNase significantly reduced mtDNA in supernatants of human lungs (Fig. 5D). Most 
importantly, treatment with DNase also reduced Il-1β release induced by PLY to a substantial extent (Fig. 5E). 
Overall, these data suggest that PLY-exposed human lung alveolar epithelial cells release mtDNA from injured 
mitochondria into the supernatant, most probably via microvesicles, which then might act as DAMP for nearby 
immune cells.
Figure 5. Pneumolysin induces extracellular release of mtDNA. (A) Relative quantification of mitochondrial 
DNA released from A549 cells in the supernatant after stimulation with the indicated amounts of PLY after 
three hours. Data are expressed as amount of mitochondrial DNA normalized to unstimulated cells (ctrl). Bars 
represent mean ± SD from n = 5 independent experiments, *P < 0.05, **P < 0.01; Kruskal-Wallis test with 
Dunn’s post-hoc test). (B) Quantification of mitochondrial DNA released from A549 control cells compared 
to ρlow A549 cells in the supernatant. Cells were stimulated with 1.0 µg/ml PLY for three hours. Bars represent 
mean ± SD from n = 3 independent experiments, *P < 0.05, one-tailed Mann-Whitney test). (C) Quantification 
of mitochondrial DNA within microvesicles released from A549 stimulated with 0.05 and 0.10 µg/ml PLY for 
four hours. Bars represent mean ± SD from n = 5 independent experiments, *P < 0.05, Kruskal-Wallis test with 
Dunn’s post-hoc test. (D) Quantification of mitochondrial DNA released from human lung tissue stimulated 
with 5.0 µg/ml PLY, 5 U/ml DNase or 5.0 µg/ml PLY + 5 U/ml DNase for eight hours. Bars represent mean ± SD 
from n ≥ 8 independent experiments, *P < 0.05, **P < 0.01; Kruskal-Wallis test with Dunn’s post-hoc test). 
(D) Quantification of IL-1β released from human lung tissue stimulated with 5.0 µg/ml PLY, 5 U/ml DNase or 
5.0 µg/ml PLY + 5 U/ml DNase for eight hours. Bars represent mean ± SD from n ≥ 8 independent experiments, 
***P < 0.001; Kruskal-Wallis test with Dunn’s post-hoc test).
www.nature.com/scientificreports/
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Discussion
In the present study, we analysed the effects of pore forming toxin PLY on mitochondria in human alveolar 
epithelial cells and human lung tissue with regard to release of DAMP molecules. First, we could charge PLY 
as the main pneumococcal virulence factor responsible for change of mitochondrial morphology, motility, and 
function. Second, essential processes such as ΔΨm sustainment and ATP generation were impaired by a strong 
and rapid [Ca2+]m overload, which alone will already have detrimental consequences for the cell. However, the 
effects on the mitochondria were not uniform and dependent on the exposed toxin dose, which would mirror 
the in vivo situation where cells are confronted with locally variable amounts of bacteria and toxin. This is of par-
ticular importance, since PLY induced cell death due to unhampered [Ca2+]c influx was concise, especially with 
high amounts of the toxin. Even these high amounts were not sufficient to release pro-apoptotic factors from the 
inner membrane space indicating that PLY induced cell death in pulmonary epithelial cells will most probably 
not follow the intrinsic pathway as assumed elsewhere and discussed below24–27. Nevertheless, high toxin amounts 
and even low sub-lytic PLY were able to reduce ΔΨm with consecutive opening of the mPTP. This opening of the 
mPTP was consequently followed by cytosolic release of mtDNA and its subsequent liberation into the microen-
vironment due to microvesicle constriction.
PLY was shown to induce acute lung failure in various animal models28,29 and is of pivotal importance for 
pneumococcal virulence in the infected host as well as for host-to-host transmission30. As part of this, the toxin 
significantly activated pro-inflammatory pathways (e.g. the inflammasome with IL-1β release) in pulmonary cells 
and human lung tissue3,31,32. Besides, it is well accepted that PLY can activate different cell death pathways such as 
apoptosis5,33, pyroptosis34, or necroptosis35. However, it remains to be clarified if both, immune activation and cell 
damage, are meshing mechanisms, which trigger an overwhelming immune response and organ failure in severe 
cases of CAP. Taken the PLY fostered IL-1β production within the human alveolus, there is currently no evidence 
if this only results from a direct interaction of the toxin with AM alone or if additional DAMP molecules from 
injured alveolar epithelial cells are involved in amplifying the signal intensity to detrimental levels3,36.
In this regard, mitochondria play a central role since they are responsible for cellular energy supply, contribute 
to cell death induction, may release mtDNA as DAMP for immune activation, and buffer [Ca2+]c overload37–40. 
It seems therefore obvious that PLY induced cell damage, which involves high [Ca2+]c, could alter such mito-
chondrial functions as an integral part of pneumococcal pathogenesis, which has also been indicated in neuronal 
studies24–27. These facts motivated us to perform an in-depth analysis of PLY effects on central mitochondrial 
functions in human lung cells and living human lung tissue.
In many organ tissues, mitochondria constitute highly mobile dynamic structures, in which hitherto only 
fragmentary understood mechanisms control their size, shape, position and dynamics. Processes like fission, 
fusion, biogenesis, or mitophagy as well as microtubule-based motility are known to regulate mitochondrial 
dynamics41. In resting lung epithelial cells as well as in human lung tissue, we observed a filamentous presentation 
of mitochondria, changing to a fragmented, swollen, and rounded phenotype after PLY exposure. Such mor-
phological alterations are supposed to be accompanied by significant changes in mitochondrial functionality, 
including processes such as calcium regulation, metabolic processes, redox homeostasis, and the regulation of cell 
fate. Indeed, mitochondrial fragmentation has been shown to limit the spread of Ca2+ signals within the mito-
chondrial network to protect cells from death induction by [Ca2+]m overload42. In addition, it is well established 
that strategic localization of mitochondria at subcellular sites of energetic demand and intracellular signaling43 
as well as distribution and accurate inheritance of mtDNA, is of critical importance to reveal proper cell function 
over time41. Therefore, the observed mitochondrial alterations of morphology and motility were a first indica-
tor for altered mitochondrial functions and induction of cell death by PLY. Interestingly, similar fragmentation 
processes and blocking of mitochondrial movement was observed in listeriolysin O treated cells44. Additionally, 
the T3SS effector VopE released by Vibrio cholerae also modulated mitochondrial dynamics by targeting of Miro 
GTPases45. The observation that enterohemorrhagic Escherichia coli hemolysin46, Helicobacter pylori effector pro-
tein VacA47, and Bacillus anthracis lethal factor48 targeted mitochondria, thereby inducing malfunction of mito-
chondrial pathways critical for cell survival, further highlighted that mitochondria are primary targets for protein 
toxins released by human pathogenic bacteria.
Well-controlled intracellular [Ca2+]c levels are of utmost importance for a balanced cellular signalling, includ-
ing the regulation of inflammatory pathways and the control of cell death. However, pore formation by PLY is a 
cellular accident, which has been shown to flood the cell with high [Ca2+]c concentrations21,23, which might also 
be true for several other pathogens manipulating host cell physiology by inducing strong Ca2+ fluxes49. Increased 
[Ca2+]c levels are first buffered by the endoplasmic reticulum and then by mitochondria39. Indeed, we observed 
an immediate and strong increase in [Ca2+]m upon PLY stimulation. Massive Ca2+ influx into mitochondria 
can lead to mitochondrial Ca2+ overload, which is assumed as a key event in apoptosis induction20 but, our data 
suggest that this response, is not uniform and has to be differentiated for their specific conditions and cell types. 
Thus, we noted activation of caspase-3/7 accompanying [Ca2+]m influx in alveolar epithelial cells as well as in 
human lung tissue, particularly after higher doses of PLY. However, in contrast to studies performed on neuronal 
cell types emphasizing a direct PLY interaction with mitochondria and release of AIF as caspase independent 
cell death pathway25,26, we found an early activation of caspase-3/7, which was not accompanied by release of 
pro-apoptotic factors such as cytochrome-c or AIF from the mitochondrion. Similarly, two other studies on 
neuronal cells demonstrated a reduction of PLY induced apoptosis by mPTP blockade24,27. Again, we likewise 
found evidence for mPTP opening but no evidence for release of inner membrane space proteins. Since the 
studies on neuronal cells highlight a direct insertion and pore formation at the mitochondrion, a release of such 
factors seems reasonable. However, by use of SIM and other advanced imaging techniques, no intracellular PLY 
was detected, neither in vitro nor in ex vivo infected human lung explants. These differences to human lung epi-
thelial cells underline that neither [Ca2+]c overload by PLY is inevitably resulting in intrinsic apoptosis induction 
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nor that caspase independent apoptotic pathways are pre-dominant after PLY stimulation. It has therefore to be 
considered that cell type and organ specific factors determine the grade of mitochondrial affection and outcome 
after a PLY attack.
In line with those studies, we revealed that PLY led to [Ca2+]m influx and to dissipation of ΔΨm accompanied 
by a decrease of mitochondrial ATP generation and an immediate drop of cytosolic ATP levels. A similar obser-
vation was described for listeriolysin O exposed epithelial cells and can therefore undoubtedly be considered as 
highly critical for the survival of cells affected by pore forming toxins44. Moreover, increasing evidence indicated 
that the activation of the innate and adaptive immune response is a highly energetic, in particular ATP consum-
ing process50. The PLY related reduction of the cells capacity to generate ATP may thus significantly reduce the 
onset and execution of anti-bacterial activities in S.pn. infected alveoli. However, a direct comparison of human 
monocyte cell lines (THP-1, U937) with A549 cells showed a higher PLY sensitivity for the epithelial cell type51. 
Thus, innate immune cells such as AM, could be more resilient to PLY and sustain mitochondrial function dur-
ing the toxin attack compared to alveolar epithelial cells, which probably release DAMP molecules to alert the 
immune system. Though, the concrete consequences for the human alveolar compartment have to be investigated 
in further studies.
Mitochondrial Ca2+ is the major inducer for opening of the mPTP, which is a large conductance pore span-
ning both mitochondrial membranes38. However, if PLY directly induces mPTP opening was so far not demon-
strated. By use of CoCl2 based mitochondrial Calcein deposition, we show for the first time PLY dependent 
opening of the mPTP and its related decrease of ΔΨm as well as mitochondrial ATP content. In addition to the 
above-mentioned effects, mPTP opening may allow for the release of mitochondrial factors into the cytosol. In 
particular, evidence is provided that mtDNA fragments may reach the cytosol via the open pore13. Since mito-
chondrial DNA contains hypomethylated CpG motifs and is therefore immunogenic, its release into the cytosol 
could be detected by innate immune receptors involving TLR9, NLRP3 and STING as a mitochondrial DAMP 
molecule, thereby inducing pro-inflammatory and type I interferon responses22,52,53.
In order to visualize mtDNA in real-time, we established a novel live-cell imaging assay based on Syto82 (see 
Supplementary Note). By using this novel live-cell imaging assay, we herein demonstrated that PLY induced 
the opening of the mPTP with a subsequent release of mtDNA into the cytosol of lung epithelial cells, which 
may lead to its detection by cytosolic innate immune receptors for induction of pro-inflammatory pathways. 
However, those local cellular effects might be strongly amplified if mtDNA would be released into the microen-
vironment or systemic circulation, which would be a reasonable mechanism in PLY induced cellular damage. 
Several studies provided evidence for correlation of circulating mtDNA with severe disease conditions such as 
trauma or sepsis and analysis of serum or blood samples from critically ill patients attributed its function not 
just as a biomarker but as a relevant DAMP22,54. Similar effects have been shown in models of acute lung injury 
and ventilator-associated pneumonia due to Pseudomonas aeruginosa17. Next to this, intratracheal instillation 
of mtDNA caused infiltration of immune cells and secretion of pro-inflammatory cytokines such as IL-1β, IL-6, 
or TNF-α via the activation of p38 MAPK pathways18, which we have demonstrated to be likewise up-regulated 
in S.pn. infection of human lung tissue6. Therefore, we tested if cytosolic mtDNA would be secreted into the 
supernatant after PLY and found evidence in human alveolar epithelial cells and even human lung tissue and we 
are able to link mtDNA release to immune activation in human lung tissue as illustrated by a reduced release of 
IL-1β into the supernatant of tissue treated with PLY in the presence of DNase. However, measurement of varia-
ble amounts of mtDNA from the unfractionated supernatants led us wonder if the DAMP might be protected by 
and packed in microvesicles. Indeed, Guescini et al. has demonstrated that exosomes may contain mtDNA and a 
couple of mitochondrial proteins55. Microvesicles are a heterogeneous group of tiny exosomes secreted by both, 
eu- and prokaryotes under several conditions but have been shown to effectively contribute to host-pathogen 
interactions and activation of immune pathways56. Isolation and analysis of microvesicles from supernatants 
of PLY stimulated human alveolar epithelial cells clearly revealed stable and significant amounts of mtDNA. 
Therefore, it is tempting to speculate that PLY related release of mtDNA containing microvesicles in the human 
alveolus can impact by several ways on the innate immune response. One obvious would be their activation of 
innate immune receptors in AM, where PLY induced inflammasome activation and other pro-inflammatory 
mediators may be further fostered. Ongoing studies have to elucidate the role for alveolar released mtDNA in the 
human alveolus under infectious conditions.
Taken together, our results provide evidence, that pneumococcal PLY disturbs mitochondrial functions in 
human lungs by Ca2+ overload, leading to breakdown of ΔΨm and opening of the mPTP. By using newly estab-
lished multi-colour spectral live-tissue imaging and a new live-cell assay, we could follow mitochondrial damage 
in the living human alveolar compartment and found mtDNA release in PLY treated human alveolar epithelial 
cells. mtDNA is released independent of activation of (intrinsic) apoptotic pathways, but, by a regulated libera-
tion in microvesicles, which may act as a pro-inflammatory DAMP indicating severe lung tissue damage to the 
host. Bacterial-toxin related disturbance of vital mitochondrial function should be considered as a significant 
cause of tissue damage in severe infections and therapeutic PLY inhibition thus promise to reduce significantly 
pneumococcal tissue damage and organ dysfunction by protecting mitochondrial function and reducing immune 
activation.
Methods
Ethics Statement. Fresh human lung explants were obtained from adult patients undergoing lung resection 
at thoracic surgery centres. Written informed consent was obtained from all patients. The study was approved 
by the local institutional review board (Ethics committee of the Charité - Universitätsmedizin Berlin, Germany, 
EA2/079/13) and performed in accordance with the approved guidelines.
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Materials. MitoTracker® Green FM, Orange CMTMRos, and Deep Red FM, Image-IT® LIVE Mitochondrial 
Transition Pore Assay Kit, SYTO® 82, tetramethylrhodamine ethyl ester perchlorate (TMRE), CellEvent™ 
Caspase-3/7 Green Detection Reagent, JC-1 and secondary Alexa Fluor conjugated antibodies were obtained 
from Life Technologies (Darmstadt, Germany). The antibody against DNA was purchased from Progen 
Biotechnik (Heidelberg, Germany), the anti-Tom20 antibody (sc-11415) was obtained from St. Cruz Biotech 
(Heidelberg, Germany) and anti-cytochrome-c antibody was obtained from BD (#556432, Heidelberg, Germany). 
Pneumolysin (PLY) was produced and purified as previously described57. 16% formaldehyde without methanol 
was obtained from electron microscopy science (Hatfield, PA) and CitiFluor™ CFM3 mounting medium was 
from Citifour (London, UK). Plasmids encoding the AT1.03YEMK fluorescence resonance energy transfer (FRET) 
sensors targeted to the cytosol (cytoATeam) and mitochondria (mitoATeam), respectively were kind gifts from 
Hiromi Imamura (Kyoto University)58. pBabe-puro-IMS-RP was a gift from Peter Sorger (Addgene plasmid 
#24535) and mEos3.2-N1 was a gift from Michael Davidson (Addgene plasmid #54525).
Bacterial strains. The S. pneumoniae strains used in this study are the D39 wildtype strain, a D39 derived 
capsule locus (cps) deletion mutant D39Δcps, the cps/pneumolysin double mutant D39ΔcpsΔply, and a 
GFP-expressing D39 strain (D39::GFP). S.pn strains were cultivated in Todd-Hewitt broth (BD, Heidelberg, 
Germany) supplemented with 0.5% yeast extract (BD, Heidelberg, Germany) to mid-log phase (A600 = 0.35–0.40) 
at 37 °C and 5% CO2 or grown on Columbia blood agar plates (BD, Heidelberg, Germany).
Cell culture and lung explant tissue. The human lung alveolar epithelial cell line A549 (ATCC, CCL-185) 
was cultured in Ham’s F12 medium (Biochrome, Berlin, Germany) supplemented with 10% (v/v) fetal bovine 
serum (FBS; Capricorn Scientific GmbH, Ebsdorfergrund, Germany) and 2 mM L-glutamine (Invitrogen Life 
Technologies) at 37 °C and 5% CO2. A549 cells were infected with S.pn. strains using a multiplicity of infection 
(MOI) of 50 in Ham’s F12 medium supplemented with 2% FBS for the indicated periods at 37 °C/5% CO2.
Primary human type II alveolar epithelial cells (AEC-II) were isolated from human lung tissue as described 
previously36. Briefly, human lung tissue was finely minced and transferred into HBSS. The tissue was filtered 
through a sterile gauze 70 µm strainer and digested with trypsin type I (SERVA, Amstetten, Austria) and elastase 
(Merck, Darmstadt, Germany) for 40 min at 37 °C. After inactivation of enzymes and recovery of the cells using 
30% FBS (GE Healthcare LifeSciences, Freiburg, Germany), the digested tissue was filtered through a sterile gauze 
100 µm strainer. Cells were seeded and expanded on irradiated NIH-3T3 (German Collection of Microorganisms 
and Cell Cultures (DSMZ), ACC 59) feeder cells in F-Medium. For stimulation experiments AEC-II were har-
vested by trypsinisation, separated from feeder cells and seeded in ibidi slides in DMEM containing 10% (v/v) 
FBS and 2 mM L-glutamine.
ρlow A549 cells were generated by incubation of A549 cells with low doses of ethidium bromide in DMEM 
(high glucose, supplemented with 10% FBS, glutamine, pyruvate and 50 µg/ml uridine) for six to seven passages 
(approx. 2 weeks).
Tumor-free normal lung tissue was processed and inoculated with 1 × 106 cfu/ml of S.pn. D39-GFP for 12 h, 
as described previously3.
To label mitochondria, cells were incubated with 100 nM of the respective MitoTracker® dyes dissolved in 
dimethyl sulfoxide, for 30 min at 37 °C/5% CO2. Membrane potential was determined by loading cells with 7.7 µM 
JC-1 or 10 nM tetramethyl-rhodamine methyl ester (TMRE) for 30 min at 37 °C/5% CO2 and washed three times 
with HBSS. TMRE is used in the nonquenching mode to assess ΔΨm, and therefore a reduction in TMRE fluo-
rescence represents mitochondrial depolarization. To visualize mPTP opening by the Calcein-CoCl2 assay mito-
chondria were stained as described above and subsequently loaded with 1 mM Calcein acetoxymethyl ester and 
CoCl2 as described by the manufacturer. Mitochondrial calcium influx was determined by loading the cells with 
4.45 µM Rhod2-AM for 30 min using FBS-free medium followed by three washing steps with HBSS.
Intracellular ATP measurement. Mitochondrial ATP levels were measured by transfecting A549 cells 
seeded in 8-well µ-slides (ibidi, Munich, Germany) with 0.4 µg plasmids encoding cytoATeam or mitoATeam 
using ViaFect transfection reagent (Promega, Wisconsin, USA). 48 hours post transfection, cells were left unstim-
ulated, infected with pneumococci as described above or stimulated with 0.25 µg/ml PLY. Stimulation with 10 µg/
ml oligomycin A served as positive control. ATP concentration was determined by spectral confocal microscopy 
using a LSM 780 confocal laser-scanning microscope equipped with a 40×/1.2 NA C-Apochromat driven by 
Zen 2012 software (Carl Zeiss, Jena, Germany). Lambda stacks were acquired using 458 nm excitation and the 
ATP content is expressed as normalized ratio of the YFP/CFP peak intensity at 530 nm (YFP) and 478 nm (CFP), 
respectively.
Indirect immunofluorescence and microscopy. Cells grown in ibibi slides were stained with 100 nM 
MitoTracker Orange, stimulated as indicated, fixed with cold methanol at −20 °C for 20 min or 3.7% formalde-
hyde in PBS for 15 min at room temperature and permeabilized with 0.5% Triton-X100 in PBS. Cells were blocked 
with PBS containing 5% goat serum, 1% bovine serum albumin (BSA) and 0.2% Tween-20. After washing with 
PBS, cells were incubated with primary antibodies diluted in PBS/1% BSA/0.2% Tween-20 over night at 4 °C. 
After three washes with PBS, cells were subjected to an overnight incubation with AlexaFluor 488/555-conjugated 
secondary antibodies at 4 °C. Cells were washed three times with PBS and nuclei were stained with DAPI for 
20 min and subsequently washed three times with PBS. Cells were mounted in CFM3 mounting medium or 
examined directly in PBS.
Confocal microscopy was performed on a LSM 780 confocal laser-scanning microscope driven by Zen 
2012 software. For live cell imaging experiments cells were imaged at 37 °C/5% CO2 in phenol red-free medium 
using a 40×/1.2 NA C-Apochromat or a 63×/1.4 NA Plan-Apochromat objective (mitochondrial motility). 3D 
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high resolution image stacks with a z-step size of 0.25 or 0.30 μm per plane were acquired using a 63×/1.4 NA 
Plan-Apochromat objective and the pinhole set to 1 airy unit in sequential imaging mode to avoid bleed-through 
of fluorescence emission.
For Airyscanning microscopy an LSM 880 with Airyscan detector equipped with a 63×/1.4 NA 
Plan-Apochromat objective controlled by Zen 2 software was used. Cells were maintained at 37 °C/5% CO2 for 
time-lapse imaging.
Structured illumination microscopy (SIM) was performed on an ELYRA PS.1 microscope with a 63×/1.40 
Plan-Apochromat objective with 405, 488, and 561 nm excitation lines (Carl-Zeiss, Jena, Germany) as described 
previously59. In brief, SIM images were acquired with five phase shifts and three or five rotations of the structured 
illumination grid and a z-step size of 120 nm. Resulting stacks were processed in ZEN 2.1 software using auto-
matically determined parameters.
Detailed information on imaging processing and analysis can be found in the SI methods.
Isolation of mitochondrial DNA and qRT-PCR. Isolation of extracellular mtDNA from A549 and 
human lung tissue stimulated with the indicated amounts of PLY was done after 3 and 8 hours, respectively. The 
supernatant containing the mtDNA was collected and centrifuged at 2100 × g for 10 min to remove cell debris. 
For microvesicle isolation, A549 were treated with PLY (50 or 100 ng/ml) in serum-free media for 4 hours. The 
microvesicles were isolated from the conditioned media as previously described with minor modifications60. 
Microvesicles were washed with PBS and processed for mtDNA analysis. Mitochondria were isolated using the 
Mitochondria Isolation Kit for Cultured Cells (Thermo Fisher, Darmstadt, Germany) as described by the manu-
facturer. mtDNA was isolated using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). Quantitative PCR 
was performed using TaqMan assays (MT-CYB, Hs 02596867_s1, Life Technologies) on an ABI 7300 instru-
ment. The amount of mtDNA in the supernatant was calculated based on a standard curve generated using puri-
fied mtDNA from isolated mitochondria. mtDNA copy number analysis was performed usingTaqMan assay for 
mtDNA and nuclear DNA (GAPDH Hs 99999905_m1, Life Technologies). Relative mtDNA copy number was 
calculated as the ratio of mtDNA abundance versus nuclear DNA abundance and normalized to the control 
group.
Statistical analysis. GraphPad Prism 7 (Version 7.01) software was used for the statistical analysis. Values 
are expressed as means ± SD from at least three independent experiments. The Mann-Whitney test was used for 
comparison of two groups and the one-way/two-way ANOVA Kruskal-Wallis with Dunn’s post-hoc test was used 
for comparison of three or more groups.
Data Availability. All data generated or analysed during this study are included in this published article and 
its Supplementary Information files.
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